240 likes | 695 Views
Case 1. . 30 yr femalePuffiness around eyes, hair loss, 15kg weight gain, cold intolerance, dry skin, nausea, giddiness, vomitingFree T4 0.2 pmol/lTSH 129 mIU/l. . Examination. Puffy around eyesSlow-relaxing reflexesCool dry skinSmall goitre - diffuseDark skin (father ? Polynesian ancestry
E N D
1. Thyroid disorders Visiting Endocrinologist,
John James Memorial Hospital,
The Canberra Hospital, Cootamundra Hospital
Visiting Fellow,
John Curtin School of Medical Research
2. Case 1
3. 30 yr female
Puffiness around eyes, hair loss, 15kg weight gain, cold intolerance, dry skin, nausea, giddiness, vomiting
Free T4 0.2 pmol/l
TSH 129 mIU/l
4. Examination Puffy around eyes
Slow-relaxing reflexes
Cool dry skin
Small goitre - diffuse
Dark skin (father ? Polynesian ancestry)
Pigment in palmar creases, striae
BP 112/80 lying, 94/70 standing
5. Investigations Synacthen test:
(rise > 200, peak > 500)
ACTH 1095
P renin 3282 H fm/L/s (130-2350)
Adrenal Ab: positive
Thyroid Ab: positive
6. Diagnosis Hashimoto’s hypothyroidism
Addison’s disease
7. Case 2
8. 50 year-old lady
Weight gain, tiredness
Saw GP because of unrelated problem
TFTs:
Examination: overweight; normal otherwise
Thyroid antibodies: negative
9. Hypothyroidism
10. Earliest change: ?FT4
leads to ?TSH
FT4 may be normal (compensated hypothyroidism)
Incidence: autoimmune 3.5/1000 women/year
High risk: high antibodies, high TSH (even 2-5 mIU/l)
Usually permanent
11. Chronic autoimmune thyroiditis Thyroid usually not palpable
Goitrous variety less common
Frequently euthyroid
May initially be thyrotoxic (Hashitoxicosis)
Thyroid peroxidase antibodies: hallmark
5% spontaneous recovery
12. Treatment Elderly, cardiac disease: initially low dose thyroxine (50 ?g daily/alt daily)
TFT monitoring:
6 weeks after dose change
Before morning dose
Half-life 7 days
Aim for normal TSH
Interfering factors: high-fibre diet, ferrous sulphate, bile acid sequestering agents
13. Treatment (contd) Pregnancy - higher dose requirements early (4 weeks)
Poor compliance commonest reason for high dose requirements
T3 therapy
Myxoedema coma
Preparation for whole body scan
With T4: improved psych. function and mood
14. Subclinical hypothyroidism High TSH, normal FT3 & FT4
Prevalence: F: 75/1,000,
M: 28/1,000
Return to normal TSH: 5%
Progression to hypothyroidism: 5%/year
Progression common with antibodies
None - mild symptoms
15. Treatment Controversial
Effects: symptomatic improvement in 1/3 in trials
? cholesterol
symptoms may improve
“Wait and see” - treat early (eg. TSH > 8)
16. Case 3
17. 61 yr male, farmer
Referred to oncologist
Tiredness, upper respiratory symptoms, dyspnoea
No heat intolerance, tremor palpitations,sweating, weight loss
18. Examination Appeared well
BP 158/70, p 90 bpm regular
Thyroid slightly enlarged, firm
Fine tremor, minimal lid lag
Reflexes, skin temp normal
CT chest, abdomen, pelvis normal
19. Investigations ESR 59 mm/r, Hb 121 g/l
ANA positive, speckled, titre 40
CRP 20 mg/l
FT4 33.3 pmol/l
TSH <0.008 mU/l
FT3 5.0 pmol/l (normal)
Anti TPO 29.0 IU/ml (normal)
20. Nuclear scan thyroid No uptake within thyroid
D/W radiologist: had iodine-containing contrast during CT scan. Had poor uptake of contrast in thyroid gland during CT scan.
21. Diagnosis Painless thyroiditis:
Thyrotoxic TFTs (mild)
High ESR, CRP
Anaemia of chronic disease
Firm thyroid gland
No uptake of tracer on scan
22. Progress 2 months later:
TSH 52.3 mU/l
FT4 7.4 pmol/l
FT3 2.5 pmol/l
Hb 124 g/l
ESR, CRP normal
23. Graves’ disease
24. Features Stimulation of TSH receptor by antibody
Features
Thyrotoxicosis
Symmetrical diffuse goitre
Ophthalmopathy (not always concurrent)
Pretibial myxoedema
May have T3 toxicosis
TPO, TSH receptor antibodies
Radionucleotide scan
Diff diag: thyroiditis, toxic nodule, factitious
25. Treatment Thionamides: Carbimazole, Propylthiouracil
? blockers (not if asthmatic)
TFT > 6wk after dose change
Remission usually occurs
Relapse rate 50-60% 1 year
SEs: agranulocytosis, rash, hepatitis
Definitive treatment
Radioactive iodine
Surgery
Drugs